Page last updated: 2024-11-03

propafenone and Dyspnea

propafenone has been researched along with Dyspnea in 3 studies

Propafenone: An antiarrhythmia agent that is particularly effective in ventricular arrhythmias. It also has weak beta-blocking activity.
propafenone : An aromatic ketone that is 3-(propylamino)propane-1,2-diol in which the hydrogen of the primary hydroxy group is replaced by a 2-(3-phenylpropanoyl)phenyl group. It is a class 1C antiarrhythmic drug with local anesthetic effects, and is used as the hydrochloride salt in the management of supraventricular and ventricular arrhythmias.

Dyspnea: Difficult or labored breathing.

Research Excerpts

ExcerptRelevanceReference
"The objective of this randomized, double-blind, placebo-controlled clinical trial was to test the efficacy and safety of a new sustained-release preparation of the antiarrhythmic drug propafenone (propafenone SR) in reducing the frequency of symptomatic arrhythmia recurrences in patients with atrial fibrillation (AF)."9.10Efficacy and safety of sustained-release propafenone (propafenone SR) for patients with atrial fibrillation. ( Carlson, M; Fava, G; Page, RL; Pritchett, EL; Undesser, K, 2003)
"The objective of this randomized, double-blind, placebo-controlled clinical trial was to test the efficacy and safety of a new sustained-release preparation of the antiarrhythmic drug propafenone (propafenone SR) in reducing the frequency of symptomatic arrhythmia recurrences in patients with atrial fibrillation (AF)."5.10Efficacy and safety of sustained-release propafenone (propafenone SR) for patients with atrial fibrillation. ( Carlson, M; Fava, G; Page, RL; Pritchett, EL; Undesser, K, 2003)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Duricova, J1
Perinova, I1
Jurckova, N1
Kacirova, I1
Grundmann, M1
Lip, GY1
Fauchier, L1
Freedman, SB1
Van Gelder, I1
Natale, A1
Gianni, C1
Nattel, S1
Potpara, T1
Rienstra, M1
Tse, HF1
Lane, DA1
Pritchett, EL1
Page, RL1
Carlson, M1
Undesser, K1
Fava, G1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Antiarrhythmic Drugs Assessment in Preventing Atrial Fibrillation[NCT02145546]Phase 4600 participants (Anticipated)Interventional2014-05-31Not yet recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

1 review available for propafenone and Dyspnea

ArticleYear
Atrial fibrillation.
    Nature reviews. Disease primers, 2016, 03-31, Volume: 2

    Topics: Ablation Techniques; Anticoagulants; Aspirin; Atrial Fibrillation; Dizziness; Dyspnea; Electric Coun

2016

Trials

1 trial available for propafenone and Dyspnea

ArticleYear
Efficacy and safety of sustained-release propafenone (propafenone SR) for patients with atrial fibrillation.
    The American journal of cardiology, 2003, Oct-15, Volume: 92, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Anti-Arrhythmia Agents; Atrial Fibrillation; C

2003

Other Studies

1 other study available for propafenone and Dyspnea

ArticleYear
Clinically important interaction between metoprolol and propafenone.
    Canadian family physician Medecin de famille canadien, 2013, Volume: 59, Issue:4

    Topics: Aged; Anti-Arrhythmia Agents; Antihypertensive Agents; Atrial Fibrillation; Cytochrome P-450 CYP2D6;

2013